ELAN
ELANCO ANIMAL HEALTH INC
Latest close $25.60 as of Aug 4, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 5 parsed filing(s) · 2 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management CIK0001897612 | Sep 30, 2025 observed Nov 14, 2025 filed · 45d Initial Schedule 13G | Initial Schedule 13G | 31.5M | 12.00% | $20.14 | $21.09 | $25.60 |
| BlackRock CIK0002012383 | Sep 30, 2025 observed Oct 17, 2025 filed · 17d Initial Schedule 13G | Initial Schedule 13G | 44.0M | 12.00% | $20.14 | $21.42 | $25.60 |
| BlackRock CIK0002012383 | Sep 30, 2024 quarter end Nov 13, 2024 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 24.3M | $25.60 |